Publications

原著論文

2024

  1. Yamagishi M*, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y*, Uchimaru K*. Mechanisms of action and resistance in histone methylation-targeted therapy. Nature, 2024 DOI: 10.1038/s41586-024-07103-x.

2023

  1. Jimbo K, Yamagishi M, Suzuki Y, Suzuki K, Mizukami M, Yokoyama K, Sato A, Nagamura-Inoue T, Nannya Y, Uchimaru K. Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution. eJHaem,2023, doi.org/10.1002/jha2.776
  2. Koseki A, Araya N, Yamagishi M (co-first author), Yamauchi J, Yagishita N, Takao N, Takahashi K, Kunitomo Y, Honma D, Araki K, Uchimaru K, Sato T, Yamano Y. EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy. Front. Microbiol., 2023, 14. doi.org/10.3389/fmicb.2023.1175762
  3. Kobayashi-Ishihara M, Smutná K, Alonso FE, Argilaguet J, Esteve-Codina A, Geiger K, Genescà M, Grau-Expósito J, Duran-Castells C, Rogenmoser S, Böttcher R, Jungfleisch J, Oliva B, Martinez JP, Li M, David M, Yamagishi M, Riol MR, Brander C, Tsunetsugu-Yokota Y, Buzon MJ, Díez Antón J, Meyerhans A. Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells. Commun. Biol.2023, 6, 487. doi: 10.1038/s42003-023-04841-y.
  4. Sato T, Yamauchi J, Yagishita N, Araya N, Takao N, Ohta Y, Inoue E, Takahashi M, Yamagishi M, Suzuki Y, Uchimaru K, Matsumoto N, Hasegawa Y, Yamano Y. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy. Bain2023, in press doi: 10.1093/brain/awad139.

2022

  1. Yamagishi M*, The role of epigenetics in T-cell lymphoma. Int J. Hematol. 2022, 116, 828-836. doi: 10.1007/s12185-022-03470-1.
  2. Tanaka M, Kunita A, Yamagishi M, Ishikawa S, Katoh H, Yamamoto H, Abe J, Arita J, Hasegawa K, Shibata T, and Ushiku T. KRAS mutation in intrahepatic cholangiocarcinoma: linkage with metastasis-free survival and reduced E-cadherin expression. Liver Int. 2022, 42, 2329-2340.
  3. Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly ALG, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K, Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano Y, Saito M. RAISING is a high-performance method for identifying random transgene integration sites. Commun Biol. 2022, 5, 535. doi: 10.1038/s42003-022-03467-w.
  4. Yamagishi M*, Suzuki Y, Watanabe T, Uchimaru K. Clonal Selection and Evolution of HTLV-1-Infected Cells Driven by Genetic and Epigenetic Alteration. Viruses. 2022, 14, 587.

2021

  1. Tan BJ, Sugata K, Reda O, Matsuo M, Uchiyama K, Miyazato P, Hahaut V, Yamagishi M, Uchimaru K, Suzuki Y, Ueno T, Suzushima H, Katsuya H, Tokunaga M, Uchiyama Y, Nakamura H, Sueoka E, Utsunomiya A, Ono M, Satou Y. HTLV-1 infection promotes T-cell activation and malignant transformation into adult T-cell leukemia/lymphoma. J Clin Invest. 2021, 131, e150472.
  2. Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, Nakashima M, Makiyama J, Iwanaga M, Fukuda T, Watanabe T, Suzuki Y, Uchimaru K. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun.2021, 12, 4821.

2020

  1. Saito M, Hasegawa H, Yamauchi S, Nakagawa S, Sasaki D, Nao N, Tanio M, Wada Y, Matsudaira T, Momose H, Kuramitsu M, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Imaizumi Y, Uchimaru K, Morishita K, Watanabe T, Miyazaki Y, Yanagihara K. A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo. Int J Hematol. 2020 Sep;112(3):300-306. doi: 10.1007/s12185-020-02935-5.
  2. Nagasaka M, Yamagishi M, Yagishita N, Araya N, Kobayashi S, Makiyama J, Kubokawa M, Yamauchi J, Hasegawa D, Coler-Reilly A, Tsutsumi S, Uemura Y, Arai A, Takata A, Inoue E, Hasegawa Y, Watanabe T, Suzuki Y, Uchimaru K, Sato T, Yamano Y. Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Proc. Natl. Acad. Sci. U S A. 2020, 117:11685-11691.
  3. Ikebe E, Matsuoka S, Tezuka K, Kuramitsu M, Okuma K, Nakashima M, Kobayashi S, Makiyama J, Yamagishi M, Oyadomari S, Uchimaru K, Hamaguchi I. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells. Blood Adv.2020, 4(9):1845-1858.
  4. Hijikata Y, Yokoyama K, Yokoyama N, Matsubara Y, Shimizu E, Nakashima M, Yamagishi M, Ota Y, Lim LA, Yamaguchi R, Ito M, Tanaka Y, Denda T, Tani K, Yotsuyanagi H, Imoto S, Miyano S, Uchimaru K, Tojo A. Successful Clinical Sequencing by Molecular Tumor Board in an Elderly Patient With Refractory Sézary Syndrome. JCO Precision Oncology, 4, 534-560, 2020. 10.1200/PO.19.00254.

2019

  1. Yamagishi M*, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, Katano H, Hishima T, Kobayashi S, Nakano K, Nakashima M, Iwanaga M, Utsunomiya A, Tanaka Y, Okada S, Tsukasaki K, Tobinai K, Araki K, Watanabe T, Uchimaru K. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. Cell Rep.2019 Nov 19;29(8):2321-2337.e7
  2. Makiyama J, Kobayashi S, Watanabe E, Ishigaki T, Kawamata T, Nakashima M, Yamagishi M, Nakano K, Tojo A, Watanabe T, Uchimaru K. CD4+ CADM1+ cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia/lymphoma. Cancer Sci. 2019 Oct 23. doi: 10.1111/cas.14219.
  3. Katsuya H, Islam S, Tan BJY, Ito J, Miyazato P, Matsuo M, Inada Y, Iwase SC, Uchiyama Y, Hata H, Sato T, Yagishita N, Araya N, Ueno T, Nosaka K, Tokunaga M, Yamagishi M, Watanabe T, Uchimaru K, Fujisawa JI, Utsunomiya A, Yamano Y, Satou Y. The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach. Cell Rep. 2019 Oct 15;29(3):724-735.e4. doi: 10.1016/j.celrep.2019.09.016.
  4. Ishikawa M, Osaki M, Yamagishi M, Onuma K, Ito H, Okada F, Endo H. Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting tumor growth. Oncogene2019 Jun;38(24):4715-4728. doi: 10.1038/s41388-019-0748-z.2018
    Yamagishi M*, Fujikawa D, Watanabe T, Uchimaru K. HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma. Front Microbiol.9:1686,

2018

  1. Kobayashi-Ishihara M, Terahara K, Martinez JP, Yamagishi M, Iwabuchi R, Brander C, Ato M, Watanabe T, Meyerhans A, Tsunetsugu-Yokota Y. HIV LTR-driven antisense RNA by itself has regulatory function and may curtail virus reactivation from latency. Front. Microbiol.9:1066, 2018 doi:10.3389/fmicb.2018.01066,

2017

  1. Yamagishi M*, Uchimaru K. Targeting EZH2 in cancer therapy. Curr. Opin. Oncol.29: 375-381, 2017.
  2. Tanaka M, Ishikawa S, Ushiku T, Morikawa T, Isagawa T, Yamagishi M, Yamamoto H, Katoh H, Takeshita K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N and Fukayama M. EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis. Oncotarget8: 99552-99566, 2017

2016

  1. Fujikawa D, Nakagawa S, Hori M, Kurokawa N, Soejima A, Nakano K, Yamochi T, Nakashima M, Kobayashi S, Tanaka Y, Iwanaga M, Utsunomiya A, Uchimaru K, Yamagishi M*, Watanabe T. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood127: 1790-1802, 2016.
  2. Tsunetsugu-Yokota Y, Kobayahi-Ishihara M, Wada Y, Terahara K, Takeyama H, Kawana-Tachikawa A, Tokunaga K, Yamagishi M, Martinez JP, Meyerhans A. Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation. Front. Microbiol.7: 1944, 2016.

2015

  1. Yamagishi M*, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, Ishida I, Okada S, Watanabe T. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci. Rep.5: 17868, 2015.
  2. Kuramitsu M, Okuma K, Yamochi T, Sato T, Sasaki S, Hasegawa H, Umeki K, Kubota R, Sobata R, Matsumoto C, Kaneko K, Naruse I, Yamagishi M, Nakashima M, Momose H, Araki K, Mizukami M, Mizusawa S, Okada Y, Ochiai M, Utsunomiya A, Koh KR, Ogata M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Satake M, Okayama A, Mochizuki M, Izumo S, Saito S, Itabashi K, Kamihira S, Yamaguchi K, Watanabe T, Hamaguchi I. Standardization of Quantitative PCR for Human T-cell Leukemia Virus Type 1 in Japan: A Collaborative Study. J. Clin. Microbiol.53: 3485-3491, 2015.
  3. Matsuda Y, Kobayashi-Ishihara M, Fujikawa D, Ishida T, Watanabe T, Yamagishi M*. Epigenetic Heterogeneity in HIV-1 Latency Establishment. Sci. Rep.5: 7701, 2015.
  4. Kuramitsu M, Okuma K, Yamagishi M, Yamochi T, Firouzi S, Momose H, Mizukami T, Takizawa K, Araki K, Sugamura K, Yamaguchi K, Watanabe T, Hamaguchi I. Identification of TL-Om1, an Adult T-Cell Leukemia (ATL) Cell Line, as Reference Material for Quantitative PCR for Human T-Lymphotropic Virus 1. J. Clin. Microbiol.53: 587-596, 2015.

2014

  1. Takahashi R, Yamagishi M (co-first author), Nakano K, Yamochi T, Yamochi T, Fujikawa D, Nakashima M, Tanaka Y, Uchimaru K, Utsunomiya A, Watanabe T. Epigenetic deregulation of Ellis Van Creveld confers robust Hedgehog signaling in adult T-cell leukemia. Cancer Sci.105: 1160-1169, 2014.
  2. Kobayashi S, Nakano K, Watanabe E, Ishigaki T, Ohno N, Yuji K, Oyaizu N, Asanuma S, Yamagishi M, Yamochi T, Watanabe N, Tojo A, Watanabe T, Uchimaru K. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma. Clin. Cancer Res. 20: 2851-2861, 2014.

2013

  1. Asanuma S, Yamagishi M, Kawanami K, Nakano K, Sato-Otsubo A, Muto S, Sanada M, Yamochi T, Kobayashi S, Utsunomiya A, Iwanaga M, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T. Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promotes T-cell growth. Cancer Sci. 104: 1097-1106, 2013.
  2. Ly BT, Chi HT, Yamagishi M, Kano Y, Hara Y, Nakano K, Sato Y, Watanabe T. Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells. PLoS One8: e66378, 2013.
  3. Nakano K, Ando T, Yamagishi M, Yokoyama K, Ishida T, Ohsugi T, Tanaka Y, Brighty DW, Watanabe T. Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication. Microbes Infect.15: 491-505, 2013.

2012

  1. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T. Polycomb-Mediated Loss of miR-31 Activates NIK-dependent NF-κB Pathway in Adult T-cell Leukemia and Other Cancers. Cancer Cell21: 121-135, 2012.
  2. Yamagishi M*, Watanabe T. New Paradigm of T cell Signaling: Learning from Malignancies (Review Article). J Clin Cell Immunol.S12: 007, 2012.
  3. Yamagishi M*, Watanabe T. Molecular Hallmarks of Adult T Cell Leukemia (Review Article). Front Microbiol.3: 334, 2012.
  4. Kobayashi-Ishihara M, Yamagishi M, Hara T, Matsuda Y, Miyake A, Nakano K, Ishida T, Watanabe T. Identification of a novel HIV-1-encoded antisense RNA, ALe, that can induce prolonged suppression of HIV-1 expression. Retrovirology 9: 38, 2012.

2011

  1. Suzuki K, Ishida T, Yamagishi M, Ahlenstiel C, Swaminathan S, Marks K, Murray D, McCartney EM, Beard MR, Alexander M, Purcell DF, Cooper DA, Watanabe T, Kelleher AD. Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific. RNA Biol.8: 1035-1046, 2011.
  2. Yamagishi M, Nakano K, Yamochi T, Miyake A, Kagami Y, Tsutsumi A, Otsubo A, Ogawa S, Utsunomiya A, Yamaguchi K, Uchimaru K, Watanabe T. Genetic and epigenetic loss of miR-31 activates NIK-dependent NF-kB pathway in Adult T-cell Leukemia. Retrovirology 8(supple 1): A128, 2011. (Meeting Abstract).
  3. Yamamoto K, Ishida T, Nakano K, Yamagishi M, Yamochi T, Tanaka Y, Furukawa Y, Nakamura Y, Watanabe T. SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax. Cancer Sci.102: 260-266, 2011.

2010

  1. Miyake A, Ishida T, Yamagishi M, Hara T, Umezawa K, Watanabe T, Horie R. Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ. Microbes Infect. 12: 400-408, 2010.

2009

  1. Yamagishi M, Ishida T, Miyake A, Cooper DA, Kelleher AD, Suzuki K, Watanabe T. Retroiral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect.11: 500-508, 2009.

 

和文総説

  1. 山岸誠「悪性リンパ腫におけるエピゲノム異常」、臨床血液、63 (9)、2022年
  2. 山岸誠「新型コロナウイルス感染症をはじめとする新興感染症の恐怖」、第24回日本歯科医学会学術大会 記録集、2022年
  3. 山岸誠「腫瘍ウイルス感染初期のエピゲノム異常と多段階発がん機構に関する多層的オミックス解析」、アグリバイオ、5 (13)、77-83、2021年
  4. 山岸誠「腫瘍ウイルス感染初期に形成されるエピゲノム異常と発がん機構の解明に向けた統合解析」、細胞、53 (9)、2021年
  5. 山岸誠、内丸薫「悪性リンパ腫に対するEZH1/2阻害薬」、血液内科、81(2)、2020年
  6. 山岸誠、鈴木穣、渡邉俊樹、内丸薫「成人T細胞白血病研究におけるシングルセル解析の有用性」、実験医学、37(20)、2019年
  7. 山岸誠、内丸薫「HTLV-1感染細胞の腫瘍化メカニズム」細胞、51(10)、8-11、2019年
  8. 山岸誠「悪性リンパ腫におけるEZH1/EZH2依存性エピゲノム異常と創薬」、血液内科、78(1)、87-92、2018年
  9. 山岸誠「HTLV-1感染細胞におけるゲノム・エピゲノム異常」、医学のあゆみ、267(10)、771-775、2018年
  10. 山岸誠「成人T細胞白血病・リンパ腫のエピゲノム異常と新規EZH1/2阻害剤の開発」、臨床血液、59(4)、432-438、2018年
  11. 山岸誠、内丸薫 特集 / 成人T細胞白血病リンパ腫(ATL)研究と診療の進歩「ATL発症における遺伝子翻訳異常」、血液内科、74(3)、314-319、2017年
  12. 山岸誠、渡邉俊樹 特集/成人T細胞白血病(ATL)研究の現状「ATL細胞におけるEZH1/2依存的なエピゲノム制御異常」、血液フロンティア、26(4)、2016年
  13. 山岸誠、渡邉俊樹 特集/血液疾患におけるエピゲノム異常と治療「ATL発症におけるエピゲノム解析の進歩 (The State of the Art in Epigenomics of Adult T Cell Leukemia)」、血液内科、66(2)、2013年2月1
  14. 山岸誠 Person人と研究「成人T細胞白血病の分子レベルの全体像と、Polycomb- miR-31- NF-kB経路の異常」、Trends in Hematological Malignancies 、4(3)：16-19、Dec. 2012.
  15. 山岸誠、渡邉俊樹 特集：microRNAの発現制御の異常と疾患「成人T細胞白血病(ATL)におけるmicroRNAの発現異常」、細胞、44(10)：15-22、2012年9月
  16. 山岸誠、渡邉俊樹 特集：ATLの基礎と臨床「ATL細胞のゲノム エピゲノム異常と発現異常」、細胞、44(8)：18-22、2012年7月
  17. 山岸誠、渡邉俊樹 総説「2.HTLV-1感染症とmiRNA」、ウイルス、62(1)：9-18、2012年6月
  18. 山岸誠、渡邉俊樹 「成人T細胞白血病から明らかになったクロストーク異常とがん」、ライフサイエンス新着論文レビュー、2012年2月

Page Top